{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T14:06:23Z","timestamp":1778594783308,"version":"3.51.4"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,11,29]],"date-time":"2014-11-29T00:00:00Z","timestamp":1417219200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Microbiol Immunol"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s00430-014-0367-9","type":"journal-article","created":{"date-parts":[[2014,12,2]],"date-time":"2014-12-02T17:05:07Z","timestamp":1417539907000},"page":"539-550","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Evaluation of the immunogenicity and protective efficacy of Killed Leishmania donovani antigen along with different adjuvants against experimental visceral leishmaniasis"],"prefix":"10.1007","volume":"204","author":[{"given":"Ankita","family":"Thakur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harpreet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sukhbir","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,11,29]]},"reference":[{"key":"367_CR1","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1017\/S0031182099004710","volume":"119","author":"IL Mauricio","year":"1999","unstructured":"Mauricio IL, Howard MK, Stothard JR, Miles MA (1999) Genomic diversity in the Leishmania donovani complex. Parasitology 119:237\u2013246","journal-title":"Parasitology"},{"key":"367_CR2","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1038\/cti.2014.4","volume":"3","author":"R Kumar","year":"2014","unstructured":"Kumar R, Engwerda C (2014) Vaccines to prevent leishmaniasis. Clin Transl Immunol 3:e13. doi: 10.1038\/cti.2014.4","journal-title":"Clin Transl Immunol"},{"key":"367_CR3","doi-asserted-by":"crossref","first-page":"4747","DOI":"10.1016\/j.vaccine.2009.05.084","volume":"27","author":"S Noazin","year":"2009","unstructured":"Noazin S, Khamesipour A, Moulton LH, Tanner M, Nasseri K, Modabber F, Sharifi I, Khalil EA, Bernal ID, Antunes CM, Smith PG (2009) Efficacy of killed whole-parasite vaccines in the prevention of leishmaniasis: a meta-analysis. Vaccine 27:4747\u20134753","journal-title":"Vaccine"},{"key":"367_CR4","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.4049\/jimmunol.163.8.4481","volume":"163","author":"RT Kenney","year":"1999","unstructured":"Kenney RT, Sacks DL, Sypek JP, Vilela L, Gam AA, Evans-Davis K (1999) Protective immunity using recombinant human IL-12 and alum as adjuvants in a primate model of cutaneous leishmaniasis. J Immunol 163:4481\u20134488","journal-title":"J Immunol"},{"key":"367_CR5","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1016\/S0264-410X(01)00058-5","volume":"19","author":"A Misra","year":"2001","unstructured":"Misra A, Dube A, Srivastava B, Sharma P, Srivastava JK, Katiyar JC, Naik S (2001) Successful vaccination against Leishmania donovani infection in Indian langur using alum-precipitated autoclaved Leishmania major with BCG. Vaccine 19:3485\u20133492","journal-title":"Vaccine"},{"key":"367_CR6","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1016\/j.vaccine.2004.03.058","volume":"22","author":"M Mohebali","year":"2004","unstructured":"Mohebali M, Khamesipour A, Mobedi I, Zarei Z, Hashemi-Fesharki R (2004) Double-blind randomized efficacy field trial of alum precipitated autoclaved Leishmania major vaccine mixed with BCG against canine visceral leishmaniasis in Meshkin-Shahr district, I.R. Iran. Vaccine 22:4097\u20134100","journal-title":"Vaccine"},{"key":"367_CR7","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0035-9203(03)90171-4","volume":"97","author":"AA Kamil","year":"2003","unstructured":"Kamil AA, Khalil EAG, Musa AM, Modabber F, Mukhtar MM, Ibrahim ME, Zijlstra EE, Sacks D, Smith PG, Zicker F, El Hassan AM (2003) Alum precipitated autoclaved L. major plus BCG, a candidate vaccine for visceral leishmaniasis: safety, skin delayed hypersensitivity response and dose finding in healthy volunteers. Trans R Soc Trop Med Hyg 97:365\u2013368","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"367_CR8","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1179\/146532806X152890","volume":"26","author":"EA Khalil","year":"2006","unstructured":"Khalil EA, Musa AM, Modabber F, El-Hassan AM (2006) Safety and immunogenicity of a candidate vaccine for visceral leishmaniasis (alum-precipitated autoclaved Leishmania major\u00a0+\u00a0BCG) in children: an extended phase II study. Ann Trop Paediatr 26:357\u2013361","journal-title":"Ann Trop Paediatr"},{"key":"367_CR9","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1475-9292-6-7","volume":"6","author":"H Ghalib","year":"2007","unstructured":"Ghalib H, Modabber F (2007) Consultation meeting on t development of therapeutic vaccines for post kala azar dermal leishmaniasis. Kinetoplastid Biol Dis 6:7\u201320. doi: 10.1186\/1475-9292-6-7","journal-title":"Kinetoplastid Biol Dis"},{"key":"367_CR10","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1590\/S0036-46652010000200006","volume":"52","author":"JM Mutiso","year":"2010","unstructured":"Mutiso JM, Macharia JC, Mutisya RM, Taracha E (2010) Subcutaneous immunization against Leishmania major\u2014infection in mice: efficacy of formalin-killed promastigotes combined with adjuvants. Rev Inst Med Trop Sao Paulo 52:95\u2013100","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"367_CR11","first-page":"423","volume":"123","author":"A Khamesipour","year":"2006","unstructured":"Khamesipour A, Rafati S, Davoudi N, Maboudi F, Modabber F (2006) Leishmaniasis vaccine candidates for development: a global overview. Indian J Med Res 123:423\u2013438","journal-title":"Indian J Med Res"},{"key":"367_CR12","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00436-008-0921-8","volume":"103","author":"H Keshavarz Valian","year":"2008","unstructured":"Keshavarz Valian H, Khoshabe Abdollah Kenedy L, Nateghi Rostami M, Miramin Mohammadi A, Khamesipour A (2008) Role of Mycobacterium vaccae in the protection induced by first generation Leishmania vaccine against murine model of leishmaniasis. Parasitol Res 103:21\u201328. doi: 10.1007\/s00436-008-0921-8","journal-title":"Parasitol Res"},{"key":"367_CR13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.it.2008.09.006","volume":"30","author":"SG Reed","year":"2009","unstructured":"Reed SG, Bertholet S, Coler RN, Friede M (2009) New horizons in adjuvants for vaccine development. Trends Immunol 30:23\u201332","journal-title":"Trends Immunol"},{"key":"367_CR14","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1179\/146532806X152890","volume":"26","author":"EA Khalil","year":"2006","unstructured":"Khalil EA, Musa AM, Modabber F, El-Hassan AM (2006) Safety and immunogenicity of a candidate vaccine for visceral leishmaniasis (alum-precipitated autoclaved Leishmania major\u00a0+\u00a0BCG) in children: an extended phase II study. Ann Trop Paediatr 26:357\u2013361","journal-title":"Ann Trop Paediatr"},{"key":"367_CR15","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.trstmh.2007.08.006","volume":"102","author":"AM Musa","year":"2008","unstructured":"Musa AM, Khalil EA, Mahgoub FA, Elgawi SH, Modabber F, Elkadaru AE et al (2008) Immunochemotherapy of persistent post-kala-azar dermal leishmaniasis: a novel approach to treatment. Trans Roy Soc Trop Med Hyg 102:58\u201363","journal-title":"Trans Roy Soc Trop Med Hyg"},{"key":"367_CR16","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1128\/IAI.71.5.2498-2507.2003","volume":"71","author":"M Martin","year":"2003","unstructured":"Martin M, Michalek SM, Katz J (2003) Role of innate immune factors in the adjuvant activity of monophosphoryl lipid A. Infect Immun 71:2498\u20132507","journal-title":"Infect Immun"},{"key":"367_CR17","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/infdis\/174.2.361","volume":"174","author":"DG Heppner","year":"1996","unstructured":"Heppner DG, Gordon DM, Gross M, Wellde B, Leitner W, Krzych U et al (1996) Safety immunogenicity and efficacy of Plasmodium falciparum repeatless circumsporozoite protein vaccine encapsulated in liposomes. J Infect Dis 174:361\u2013366","journal-title":"J Infect Dis"},{"key":"367_CR18","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1086\/515657","volume":"178","author":"JA Stoute","year":"1998","unstructured":"Stoute JA, Kester KE, Krzych U, Wellde BT, Hall T, White K et al (1998) Long-term efficacy and immune responses following immunization with the RTS, S malaria vaccine. J Infect Dis 178:1139\u20131144","journal-title":"J Infect Dis"},{"key":"367_CR19","first-page":"67","volume":"381","author":"K Oda","year":"2000","unstructured":"Oda K, Matsuda H, Murakami T, Katayama S, Ohgitani T, Yoshikawa M (2000) Adjuvant and haemolytic activities of 47 saponins derived from medical and food plants. Biol Chem 381:67\u201374","journal-title":"Biol Chem"},{"key":"367_CR20","doi-asserted-by":"crossref","first-page":"6176","DOI":"10.1016\/j.vaccine.2007.06.005","volume":"25","author":"FN Santos","year":"2007","unstructured":"Santos FN, Borja-Cabrera GP, Miyashiro LM, Grechi J, Reis AB, Moreira MAB, Martins Filho OA, Menz I, Pessoa LM, Goncalves PR, Palatnik M, Palatnik-de-Sousa CB (2007) Immunotherapy against experimental canine visceral leishmaniasis with the saponin enriched-Leishmune\u00ae vaccine. Vaccine 25:6176\u20136190","journal-title":"Vaccine"},{"key":"367_CR21","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1016\/j.vaccine.2008.07.029","volume":"26","author":"GP Borja-Cabrera","year":"2008","unstructured":"Borja-Cabrera GP, Santos FN, Bauer FS, Parra LE, Menz I, Morgado A, Soares IS, Batista LM, Palatnik-De-Sousa CB (2008) Immunogenicity assay of the Leishmune\u00ae vaccine against canine visceral leishmaniasis in Brazil. Vaccine 26:4991\u20134997","journal-title":"Vaccine"},{"key":"367_CR22","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.vaccine.2008.11.104","volume":"27","author":"MSS Araujo","year":"2009","unstructured":"Araujo MSS, de Andrade RA, Sathler Avelar R, Teixeira-Carvalho A, Andrade MC, Vianna LR, Mayrink W, Reis AB, Malaguias LC, Mello MN, Martins-Filho OA (2009) T-cell-derived cytokines, nitric oxide production by peripheral blood monocytes and seric anti-Leishmania (Leishmania) chagasi IgG subclass patterns following immunization against canine visceral leishmaniasis using Leishvaccine and Leishmune. Vaccine 27:1008\u20131017","journal-title":"Vaccine"},{"key":"367_CR23","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.copbio.2004.10.005","volume":"15","author":"D Felnerova","year":"2004","unstructured":"Felnerova D, Viret JF, Gluck R, Moser C (2004) Liposomes and virosomes as delivery systems for antigens, nucleic acids and drugs. Curr Opin Biotechnol 15:518\u2013529","journal-title":"Curr Opin Biotechnol"},{"key":"367_CR24","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1128\/IAI.65.6.2371-2377.1997","volume":"65","author":"F Afrin","year":"1997","unstructured":"Afrin F, Ali N (1997) Adjuvanticity and protective immunity elicited by Leishmania donovani antigens encapsulated in positively charged liposomes. Infect Immun 65:2371\u20132377","journal-title":"Infect Immun"},{"key":"367_CR25","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265\u2013275","journal-title":"J Biol Chem"},{"key":"367_CR26","first-page":"119","volume":"30","author":"DJ Bradley","year":"1977","unstructured":"Bradley DJ, Kirkley J (1977) Regulation of Leishmania population within the host. I. The variable course of Leishmania donovani infections in mice. Clin Exp Immunol 30:119\u2013129","journal-title":"Clin Exp Immunol"},{"key":"367_CR27","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s00436-008-1150-x","volume":"103","author":"S Kaur","year":"2008","unstructured":"Kaur S, Kaur T, Garg N, Mukherjee S, Raina P, Athokpam V (2008) Effect of dose and route of inoculation on the generation of CD4+ Th1\/Th2 type of immune response in murine visceral leishmaniasis. Parasitol Res 103:1413\u20131419","journal-title":"Parasitol Res"},{"key":"367_CR28","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1128\/IAI.72.2.863-870.2004","volume":"72","author":"R Ravindran","year":"2004","unstructured":"Ravindran R, Anam K, Bairagi BC, Saha B, Pramanik N, Guha SK et al (2004) Characterization of immunoglobulin G and its subclass response to Indian kala-azar infection before and after chemotherapy. Infect Immun 72:863\u2013870","journal-title":"Infect Immun"},{"key":"367_CR29","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s12639-012-0171-7","volume":"37","author":"T Kaur","year":"2013","unstructured":"Kaur T, Thakur A, Kaur S (2013) Protective immunity using MPL-A and autoclaved Leishmania donovani as adjuvants along with a cocktail vaccine against murine model of visceral leishmaniasis. J Parasit Dis 37:231\u2013239. doi: 10.1007\/s12639-012-0171-7","journal-title":"J Parasit Dis"},{"key":"367_CR30","doi-asserted-by":"crossref","first-page":"896","DOI":"10.4049\/jimmunol.165.2.896","volume":"165","author":"AY Park","year":"2000","unstructured":"Park AY, Hondowicz BD, Scott P (2000) IL-12 is required to maintain a Th-1 response during Leishmania major infection. J Immunol 165:896\u2013902","journal-title":"J Immunol"},{"key":"367_CR31","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00436-011-2806-5","volume":"111","author":"VH Shargh","year":"2012","unstructured":"Shargh VH, Jaafari MR, Khamesipour A, Jaafari I, Jalali SA, Abbasi A, Badiee A (2012) Cationic liposomes containing soluble Leishmania antigens (SLA) plus CpG ODNs induce protection against murine model of leishmaniasis. Parasitol Res 111:105\u2013114. doi: 10.1007\/s00436-011-2806-5","journal-title":"Parasitol Res"},{"key":"367_CR32","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1016\/j.vaccine.2010.01.015","volume":"28","author":"R Nagill","year":"2010","unstructured":"Nagill R, Kaur S (2010) Enhanced efficacy and immunogenicity of 78\u00a0kDa antigen formulated in various adjuvants against murine visceral leishmaniasis. Vaccine 28:4002\u20134012","journal-title":"Vaccine"},{"key":"367_CR33","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00002371-199402000-00006","volume":"15","author":"GL Gustafson","year":"1994","unstructured":"Gustafson GL, Rhodes MJ (1994) Effects of tumor necrosis factor and dexamethasone on the regulation of interferon-gamma induction by monophosphoryl lipid A. J Immunother Emphasis Tumor Immunol 15:129\u2013133","journal-title":"J Immunother Emphasis Tumor Immunol"},{"key":"367_CR34","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1016\/S0264-410X(03)00255-X","volume":"21","author":"MR Caro","year":"2003","unstructured":"Caro MR, Ortega N, Buend\u00eda AJ, Gallego MC, Del R\u00edo L, Cuello F, Salinas J (2003) Relationship between the immune response and protection conferred by new designed inactivated vaccines against ovine enzootic abortion in a mouse model. Vaccine 21:3126\u20133136","journal-title":"Vaccine"},{"key":"367_CR35","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.vetimm.2006.10.008","volume":"115","author":"AJ Buend\u00eda","year":"2007","unstructured":"Buend\u00eda AJ, Nicol\u00e1s L, Ortega N, Gallego MC, Martinez CM, Sanchez J, Caro MR, Navarro JA, Salinas J (2007) Characterization of a murine model of intranasal infection suitable for testing vaccines against C. abortus. Vet Immunol Immunopathol 115:76\u201386","journal-title":"Vet Immunol Immunopathol"},{"key":"367_CR36","first-page":"89","volume":"27","author":"M Nateghi Rostami","year":"2010","unstructured":"Nateghi Rostami M, Keshavarz H, Khamesipour A (2010) Immune responses of BALB\/c mice against an experimental vaccine of alum precipitated autoclaved Leishmania major (Alum-ALM) mixed with BCG or mycobacterium vaccae. Trop Biomed 27:89\u2013102","journal-title":"Trop Biomed"},{"key":"367_CR37","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1098\/rstb.1984.0111","volume":"307","author":"JG Howard","year":"1984","unstructured":"Howard JG, Liew FY (1984) Mechanisms of acquired immunity in leishmaniasis. Philos Trans R Soc Lond B Biol Sci 307:87\u201398","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"367_CR38","doi-asserted-by":"crossref","first-page":"6544","DOI":"10.1016\/j.vaccine.2007.05.042","volume":"25","author":"S Bhowmick","year":"2007","unstructured":"Bhowmick S, Ravindran R, Ali N (2007) Leishmanial antigens in liposomes promote protective immunity and provide immunotherapy against visceral leishmaniasis via polarized Th1 response. Vaccine 25:6544\u20136556","journal-title":"Vaccine"},{"key":"367_CR39","doi-asserted-by":"crossref","first-page":"5708","DOI":"10.1016\/j.vaccine.2006.04.062","volume":"24","author":"MR Jaafari","year":"2006","unstructured":"Jaafari MR, Ghafarian A, Farrokh-Gisour A, Samiei A, Kheiri MT, Mahboudi F, Barkhordari F, Khamesipour A, McMaster WR (2006) Immune response and protection assay of recombinant major surface glycoprotein of Leishmania (rgp63) reconstituted with liposomes in BALB\/c mice. Vaccine 24:5708\u20135717","journal-title":"Vaccine"},{"key":"367_CR40","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.exppara.2008.09.019","volume":"121","author":"S Bhardwaj","year":"2009","unstructured":"Bhardwaj S, Vasishta RK, Arora SK (2009) Vaccination with a novel recombinant Leishmania antigen plus MPL provides partial protection against L. donovani challenge in experimental model of visceral leishmaniasis. Exp Parasitol 121:29\u201337","journal-title":"Exp Parasitol"},{"key":"367_CR41","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1051\/vetres:2005033","volume":"36","author":"RT Fujiwara","year":"2005","unstructured":"Fujiwara RT, Vale AM, Franca-Silva JC, Costa RT, Quetz JS, Martins-Filho OA et al (2005) Immunogenicity in dogs of three recombinant antigens (TSA, LeIF and LmSTI1) potential vaccine candidates for canine visceral leishmaniasis. Vet Res 36:827\u2013838","journal-title":"Vet Res"},{"key":"367_CR42","first-page":"639","volume":"27","author":"M Tafaghodi","year":"2010","unstructured":"Tafaghodi M, Eskandari M, Kharazizadeh M, Khamesipour A, Jaafari MR (2010) Immunization against leishmaniasis by PLGA nanospheres loaded with an experimental autoclaved Leishmania major (ALM) and Quillaja saponins. Trop Biomed 27:639\u2013650","journal-title":"Trop Biomed"},{"key":"367_CR43","first-page":"623","volume":"11","author":"J El-On","year":"2009","unstructured":"El-On J (2009) Current status and perspectives of the immunotherapy of leishmaniasis. Isr Med Assoc J 11:623\u2013628","journal-title":"Isr Med Assoc J"},{"key":"367_CR44","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.4049\/jimmunol.143.12.4244","volume":"143","author":"KE Squires","year":"1989","unstructured":"Squires KE, Schreiber RD, McElrath MJ, Rubin BY, Anderson SL, Murray HW (1989) Experimental visceral leishmaniasis: role of endogenous IFN-\u03b3 in host defense and tissue granulomatous response. J Immunol 143:4244\u20134249","journal-title":"J Immunol"},{"key":"367_CR45","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1128\/IAI.62.3.1058-1063.1994","volume":"62","author":"GD Miralles","year":"1994","unstructured":"Miralles GD, Stoeckle MY, McDermott DF, Finkelman FD, Murray HW (1994) Th1 and Th2 cell-associated cytokines in experimental visceral leishmaniasis. Infect Immun 62:1058\u20131063","journal-title":"Infect Immun"},{"key":"367_CR46","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1086\/516482","volume":"175","author":"HW Murray","year":"1997","unstructured":"Murray HW (1997) Endogenous interleukin-12 regulates acquired resistance in experimental visceral leishmaniasis. J Infect Dis 175:1477\u20131479","journal-title":"J Infect Dis"},{"key":"367_CR47","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.4049\/jimmunol.175.4.2517","volume":"175","author":"CB Stober","year":"2005","unstructured":"Stober CB, Lange UG, Roberts MT, Alcam A, Blackwell JM (2005) IL-10 from regulatory T cells determines vaccine efficacy in murine Leishmania major infection. J Immunol 175:2517\u20132524","journal-title":"J Immunol"},{"key":"367_CR48","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0065-2776(08)60912-8","volume":"74","author":"W Solbach","year":"2000","unstructured":"Solbach W, Laskay T (2000) The host response to Leishmania infection. Adv Immunol 74:275\u2013317","journal-title":"Adv Immunol"},{"key":"367_CR49","doi-asserted-by":"crossref","first-page":"17292","DOI":"10.1073\/pnas.1004879107","volume":"107","author":"E Mohr","year":"2010","unstructured":"Mohr E, Cunningham AF, Toellner K-M, Bobat S, Coughlan RE, Bird RA, MacLennan IC, Serre K (2010) IFN-gamma produced by CD8 T cells induces T-bet-dependent and -independent class switching in B cells in responses to alum-precipitated protein vaccine. Proc Natl Acad Sci USA 107:17292\u201317297","journal-title":"Proc Natl Acad Sci USA"},{"key":"367_CR50","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1093\/infdis\/jir461","volume":"204","author":"S Gautam","year":"2011","unstructured":"Gautam S, Kumar R, Maurya R, Nylen S, Ansari N, Rai M et al (2011) IL-10 neutralization promotes parasite clearance in splenic aspirate cells from patients with visceral leishmaniasis. J Infect Dis 204:1134\u20131137","journal-title":"J Infect Dis"},{"key":"367_CR51","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.4049\/jimmunol.175.4.2517","volume":"175","author":"CB Stober","year":"2005","unstructured":"Stober CB, Lange UG, Roberts MTM, Alcami A, Blackwell JM (2005) IL-10 from regulatory T cells determines vaccine efficacy in murine Leishmania major infection. J Immunol 175:2517\u20132524","journal-title":"J Immunol"},{"key":"367_CR52","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/0092-8674(93)90542-X","volume":"75","author":"Y Kamogawa","year":"1993","unstructured":"Kamogawa Y, Minasi LA, Carding SR, Bottomly K, Flavell RA (1993) The relationship of IL-4 and IFN gamma-producing T cells studied by lineage ablation of IL-4 producing cells. Cell 75:985\u2013995","journal-title":"Cell"},{"key":"367_CR53","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/eji.1830220511","volume":"22","author":"C Platzer","year":"1992","unstructured":"Platzer C, Richter G, Uberla K, Muller W, Blocker H, Diamantstein T et al (1992) Analysis of cytokine mRNA levels in interleukin-4-transgenic mice by quantitative polymerase chain reaction. Eur J Immunol 22:1179\u20131184","journal-title":"Eur J Immunol"},{"key":"367_CR54","first-page":"357","volume":"85","author":"A Noble","year":"1995","unstructured":"Noble A, Kemeny DM (1995) Interleukin-4 enhances interferon-gamma synthesis but inhibits development of interferon-gamma-producing cells. Immunology 85:357\u2013363","journal-title":"Immunology"},{"key":"367_CR55","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1073\/pnas.97.7.3406","volume":"97","author":"LR Huang","year":"2000","unstructured":"Huang LR, Chen FL, Chen YT, Lin YM, Kung JT (2000) Potent induction of long-term CD8+ T cell memory by short-term IL-4 exposure during T cell receptor stimulation. Proc Natl Acad Sci USA 97:3406\u20133411","journal-title":"Proc Natl Acad Sci USA"},{"key":"367_CR56","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1084\/jem.20042463","volume":"202","author":"A Morrot","year":"2005","unstructured":"Morrot A, Hafalla JC, Cockburn IA, Carvalho LH, Zavala F (2005) IL-4 receptor expression on CD8+ T cells is required for the development of protective memory responses against liver stages of malaria parasites. J Exp Med 202:551\u2013560","journal-title":"J Exp Med"},{"key":"367_CR57","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/nm933","volume":"9","author":"S Stager","year":"2003","unstructured":"Stager S, Alexander J, Kirby AC, Botto M, Rooijen NV, Smith DF et al (2003) Natural antibodies and complement are endogenous adjuvants for vaccine-induced CD8+ T-cell responses. Nat Med 9:1287\u20131292","journal-title":"Nat Med"},{"key":"367_CR58","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1002\/1521-4141(200010)30:10<2935::AID-IMMU2935>3.0.CO;2-Q","volume":"30","author":"J Alexander","year":"2000","unstructured":"Alexander J, Carter KC, Al-Fasi N, Satoskar A, Brombacher F (2000) Endogenous IL-4 is necessary for effective drug therapy against visceral leishmaniasis. Eur J Immunol 30:2935\u20132943","journal-title":"Eur J Immunol"},{"key":"367_CR59","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/infdis\/jir080","volume":"204","author":"E McFarlane","year":"2011","unstructured":"McFarlane E, Carter KC, McKenzie AN, Kaye PM, Brombacher F, Alexander J (2011) Endogenous IL-13 plays a crucial role in liver granuloma maturation during Leishmania donovani infection, independent of IL-4R\u03b1-responsive macrophages and neutrophils. J Infect Dis 204:36\u201343","journal-title":"J Infect Dis"},{"key":"367_CR60","doi-asserted-by":"crossref","first-page":"5956","DOI":"10.1128\/IAI.00944-07","volume":"75","author":"R Basu","year":"2007","unstructured":"Basu R, Bhaumik S, Haldar AK, Naskar K, De T, Dana SK, Walden P, Roy S (2007) Hybrid cell vaccination resolves Leishmania donovani infection by eliciting a strong CD8\u00a0+\u00a0cytotoxic T-lymphocyte response with concomitant suppression of interleukin-10 (IL-10) but not IL-4 or IL-13. Infect Immun 75:5956\u20135966","journal-title":"Infect Immun"},{"key":"367_CR61","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1016\/j.vaccine.2012.01.070","volume":"30","author":"DS Watson","year":"2012","unstructured":"Watson DS, Endsley AN, Huang L (2012) Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens. Vaccine 30:2256\u20132272","journal-title":"Vaccine"},{"key":"367_CR62","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1128\/IAI.01739-07","volume":"77","author":"S Bhowmick","year":"2009","unstructured":"Bhowmick S, Mazumdar T, Ali N (2009) Vaccination route that induces transforming growth factor beta production fails to elicit protective immunity against Leishmania donovani infection. Infect Immun 77:1514\u20131523. doi: 10.1128\/IAI.01739-07","journal-title":"Infect Immun"},{"key":"367_CR63","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1128\/CVI.00153-07","volume":"14","author":"GL Morefield","year":"2007","unstructured":"Morefield GL, Hawkins LD, Ishizaka ST, Kissner TL, Ulrich RG (2007) Synthetic Toll-like receptor 4 agonist enhances vaccine efficacy in an experimental model of toxic shock syndrome. Clin Vaccine Immunol 14:1499\u20131504","journal-title":"Clin Vaccine Immunol"},{"key":"367_CR64","doi-asserted-by":"crossref","first-page":"10413","DOI":"10.1128\/JVI.00928-10","volume":"84","author":"EG Rhee","year":"2010","unstructured":"Rhee EG, Kelley RP, Agarwal I, Lynch DM, La Porte A, Simmons NL et al (2010) TLR4 ligands augment antigen-specific CD8+ T lymphocyte responses elicited by a viral vaccine vector. J Virol 84:10413\u201310419. doi: 10.1128\/JVI.00928-10","journal-title":"J Virol"},{"key":"367_CR65","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1590\/S0036-46652012000100007","volume":"54","author":"JM Mutiso","year":"2012","unstructured":"Mutiso JM, Macharia JC, Taracha E, Wafula K, Rikoi H, Gicheru MM (2012) Safety and Skin delayed-type hypersensitivity response in vervet monkeys immunized with Leishmania donovani sonicate antigen delivered with adjuvants. Rev Inst Med Trop Sao Paulo 54:37\u201341","journal-title":"Rev Inst Med Trop Sao Paulo"}],"container-title":["Medical Microbiology and Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-014-0367-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00430-014-0367-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-014-0367-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,30]],"date-time":"2023-07-30T11:26:28Z","timestamp":1690716388000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00430-014-0367-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,29]]},"references-count":65,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["367"],"URL":"https:\/\/doi.org\/10.1007\/s00430-014-0367-9","relation":{},"ISSN":["0300-8584","1432-1831"],"issn-type":[{"value":"0300-8584","type":"print"},{"value":"1432-1831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,29]]}}}